Orca Bio rallies $192m Series D

Menlo Park, California-based Orca Bio, a developer of high precision allogeneic cell therapies, has raised $192 million in Series D financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this